News

Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...
According to the Market Research Blog, "the total U.S. weight loss market is estimated to have grown to a historic peak of ...
A wellness influencer named Janelle Rohner has come under fire after withholding the fact that she was using a GLP-1 weight ...
The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or ...
VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...
People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...
Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.
Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...